In the BioHarmony Drug Report Database

"Preview" Icon

Aminolevulinic acid

Ameluz, Gleolan, Levulan, Gliolan (aminolevulinic acid) is a small molecule pharmaceutical. Aminolevulinic acid was first approved as Ameluz on 1999-12-03. It is used to treat actinic keratosis in the USA. It has been approved in Europe to treat actinic keratosis, basal cell carcinoma, and glioma. Levulan kerastick’s patent is valid until 2038-01-12 (FDA).

 

Trade Name

 

Ameluz, Gliolan
 

Common Name

 

aminolevulinic acid
 

ChEMBL ID

 

CHEMBL601
 

Indication

 

actinic keratosis, basal cell carcinoma, glioma
 

Drug Class

 

Image (chem structure or protein)

Aminolevulinic acid structure rendering